Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, N-Methyl-D-Aspartate | 38 | 2023 | 263 | 16.220 |
Why?
|
Neuralgia | 34 | 2023 | 254 | 13.180 |
Why?
|
Posterior Horn Cells | 47 | 2023 | 127 | 11.710 |
Why?
|
Paraventricular Hypothalamic Nucleus | 36 | 2024 | 134 | 11.570 |
Why?
|
Spinal Cord | 65 | 2023 | 701 | 10.880 |
Why?
|
Rats, Sprague-Dawley | 145 | 2024 | 2120 | 8.670 |
Why?
|
Rats | 166 | 2024 | 6208 | 7.540 |
Why?
|
Sympathetic Nervous System | 30 | 2023 | 163 | 7.530 |
Why?
|
Hypertension | 26 | 2023 | 1584 | 6.290 |
Why?
|
Excitatory Postsynaptic Potentials | 46 | 2024 | 249 | 6.220 |
Why?
|
Neurons | 47 | 2024 | 2386 | 6.110 |
Why?
|
Neurons, Afferent | 35 | 2022 | 124 | 6.010 |
Why?
|
Sensory Receptor Cells | 16 | 2023 | 147 | 5.930 |
Why?
|
Hyperalgesia | 25 | 2023 | 237 | 5.420 |
Why?
|
Ganglia, Spinal | 32 | 2022 | 244 | 5.110 |
Why?
|
Synaptic Transmission | 27 | 2021 | 449 | 5.070 |
Why?
|
gamma-Aminobutyric Acid | 29 | 2016 | 272 | 4.800 |
Why?
|
Glutamic Acid | 25 | 2021 | 319 | 4.550 |
Why?
|
Calcium Channels, L-Type | 7 | 2021 | 78 | 4.540 |
Why?
|
Receptors, Opioid, mu | 16 | 2022 | 87 | 4.330 |
Why?
|
Pain | 37 | 2022 | 1694 | 4.280 |
Why?
|
Synapses | 24 | 2024 | 530 | 4.270 |
Why?
|
Receptors, AMPA | 8 | 2024 | 78 | 4.060 |
Why?
|
Morphine | 20 | 2023 | 321 | 3.990 |
Why?
|
Hypothalamus | 12 | 2023 | 255 | 3.760 |
Why?
|
Diabetic Neuropathies | 13 | 2019 | 102 | 3.660 |
Why?
|
TRPV Cation Channels | 14 | 2019 | 76 | 3.540 |
Why?
|
Analgesics, Opioid | 28 | 2023 | 1426 | 3.300 |
Why?
|
Animals | 226 | 2024 | 61014 | 3.230 |
Why?
|
Receptors, Muscarinic | 18 | 2016 | 70 | 3.230 |
Why?
|
Presynaptic Terminals | 14 | 2020 | 117 | 3.190 |
Why?
|
Nitric Oxide | 18 | 2017 | 659 | 2.910 |
Why?
|
Receptors, Metabotropic Glutamate | 8 | 2020 | 63 | 2.770 |
Why?
|
Nociceptors | 19 | 2019 | 94 | 2.740 |
Why?
|
Rats, Inbred WKY | 22 | 2023 | 112 | 2.730 |
Why?
|
Analgesics | 18 | 2023 | 400 | 2.720 |
Why?
|
Calcium Channels | 10 | 2019 | 200 | 2.670 |
Why?
|
Rats, Inbred SHR | 21 | 2023 | 112 | 2.660 |
Why?
|
Receptors, Presynaptic | 8 | 2022 | 27 | 2.520 |
Why?
|
Chronic Pain | 6 | 2023 | 256 | 2.520 |
Why?
|
Up-Regulation | 14 | 2022 | 2480 | 2.480 |
Why?
|
Nociception | 9 | 2022 | 47 | 2.410 |
Why?
|
Calcineurin | 7 | 2024 | 136 | 2.400 |
Why?
|
Patch-Clamp Techniques | 34 | 2020 | 399 | 2.320 |
Why?
|
Protein Kinase C | 8 | 2022 | 397 | 2.310 |
Why?
|
Neuronal Plasticity | 12 | 2022 | 317 | 2.280 |
Why?
|
Receptors, GABA-B | 9 | 2010 | 33 | 2.220 |
Why?
|
Calcineurin Inhibitors | 5 | 2024 | 70 | 2.200 |
Why?
|
Casein Kinase II | 5 | 2014 | 62 | 2.150 |
Why?
|
Afferent Pathways | 16 | 2009 | 64 | 2.150 |
Why?
|
Spinal Nerves | 9 | 2017 | 45 | 2.120 |
Why?
|
Peripheral Nerve Injuries | 7 | 2018 | 62 | 1.930 |
Why?
|
Neural Inhibition | 16 | 2010 | 155 | 1.890 |
Why?
|
Blood Pressure | 20 | 2023 | 1527 | 1.860 |
Why?
|
Excitatory Amino Acid Antagonists | 17 | 2017 | 152 | 1.850 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 12 | 2022 | 33 | 1.810 |
Why?
|
Diabetes Mellitus, Experimental | 10 | 2011 | 230 | 1.780 |
Why?
|
Male | 181 | 2024 | 127630 | 1.770 |
Why?
|
Tacrolimus | 5 | 2024 | 347 | 1.720 |
Why?
|
Calcium Channels, T-Type | 5 | 2011 | 27 | 1.710 |
Why?
|
Calcium Channels, N-Type | 5 | 2015 | 40 | 1.640 |
Why?
|
Inhibitory Postsynaptic Potentials | 9 | 2010 | 48 | 1.630 |
Why?
|
Receptor, Angiotensin, Type 1 | 3 | 2023 | 80 | 1.600 |
Why?
|
Solute Carrier Family 12, Member 2 | 3 | 2023 | 12 | 1.530 |
Why?
|
Angiotensin II | 5 | 2018 | 199 | 1.490 |
Why?
|
Acute Pain | 3 | 2022 | 49 | 1.480 |
Why?
|
Receptor, Muscarinic M2 | 9 | 2018 | 24 | 1.480 |
Why?
|
Membrane Potentials | 16 | 2014 | 435 | 1.460 |
Why?
|
In Vitro Techniques | 27 | 2014 | 1638 | 1.410 |
Why?
|
Histone-Lysine N-Methyltransferase | 3 | 2020 | 463 | 1.400 |
Why?
|
Pain Measurement | 19 | 2019 | 996 | 1.360 |
Why?
|
Pain Threshold | 17 | 2018 | 132 | 1.340 |
Why?
|
Chlorides | 3 | 2016 | 143 | 1.340 |
Why?
|
Diterpenes | 16 | 2021 | 111 | 1.300 |
Why?
|
Receptors, Adrenergic, alpha-2 | 7 | 2011 | 23 | 1.230 |
Why?
|
Glycine | 9 | 2014 | 305 | 1.220 |
Why?
|
Calcium | 11 | 2024 | 1558 | 1.210 |
Why?
|
Bradykinin | 16 | 2007 | 83 | 1.210 |
Why?
|
Medulla Oblongata | 6 | 2014 | 45 | 1.100 |
Why?
|
Drug Tolerance | 4 | 2019 | 117 | 1.090 |
Why?
|
Autonomic Nervous System | 3 | 2013 | 67 | 1.060 |
Why?
|
4-Aminopyridine | 5 | 2014 | 43 | 1.050 |
Why?
|
Dose-Response Relationship, Drug | 31 | 2020 | 5030 | 1.050 |
Why?
|
Heart | 10 | 2007 | 1255 | 1.040 |
Why?
|
Long-Term Potentiation | 2 | 2021 | 175 | 1.030 |
Why?
|
Receptor, Muscarinic M4 | 7 | 2011 | 21 | 1.010 |
Why?
|
Clonidine | 9 | 2007 | 74 | 0.990 |
Why?
|
Injections, Spinal | 23 | 2016 | 267 | 0.990 |
Why?
|
Potassium Channel Blockers | 11 | 2014 | 111 | 0.980 |
Why?
|
Adrenergic alpha-Agonists | 9 | 2008 | 44 | 0.970 |
Why?
|
Mice, Knockout | 17 | 2022 | 5804 | 0.960 |
Why?
|
Ion Channels | 3 | 2020 | 226 | 0.950 |
Why?
|
Electrophysiology | 18 | 2014 | 348 | 0.940 |
Why?
|
Vesicular Glutamate Transport Protein 2 | 3 | 2021 | 25 | 0.940 |
Why?
|
DNA Demethylation | 1 | 2023 | 11 | 0.940 |
Why?
|
Bicuculline | 13 | 2016 | 56 | 0.930 |
Why?
|
Muscarinic Agonists | 11 | 2010 | 40 | 0.920 |
Why?
|
Receptor, Cannabinoid, CB1 | 3 | 2020 | 35 | 0.910 |
Why?
|
Mice | 32 | 2023 | 35331 | 0.910 |
Why?
|
Drug Interactions | 15 | 2016 | 573 | 0.900 |
Why?
|
Enkephalin, D-Penicillamine (2,5)- | 5 | 2008 | 16 | 0.890 |
Why?
|
GABA Antagonists | 13 | 2010 | 54 | 0.880 |
Why?
|
Amitriptyline | 1 | 2023 | 38 | 0.880 |
Why?
|
Plant Lectins | 5 | 2008 | 28 | 0.880 |
Why?
|
Receptor, Metabotropic Glutamate 5 | 4 | 2023 | 19 | 0.880 |
Why?
|
Protein Subunits | 4 | 2021 | 283 | 0.870 |
Why?
|
Acetylcholine | 6 | 2009 | 101 | 0.870 |
Why?
|
Receptors, Glutamate | 3 | 2017 | 21 | 0.860 |
Why?
|
Receptors, Cannabinoid | 1 | 2022 | 9 | 0.840 |
Why?
|
Nociceptive Pain | 2 | 2019 | 9 | 0.820 |
Why?
|
Streptozocin | 3 | 2019 | 73 | 0.820 |
Why?
|
Nerve Fibers, Unmyelinated | 4 | 2007 | 15 | 0.820 |
Why?
|
Homeostasis | 4 | 2016 | 947 | 0.820 |
Why?
|
6-Cyano-7-nitroquinoxaline-2,3-dione | 11 | 2014 | 47 | 0.810 |
Why?
|
Cannabinoids | 1 | 2022 | 43 | 0.800 |
Why?
|
Theta Rhythm | 1 | 2021 | 30 | 0.800 |
Why?
|
Potassium Channels | 2 | 2015 | 164 | 0.800 |
Why?
|
Adrenergic Fibers | 2 | 2017 | 8 | 0.780 |
Why?
|
Heart Rate | 7 | 2011 | 752 | 0.780 |
Why?
|
Receptors, Drug | 4 | 2004 | 50 | 0.770 |
Why?
|
Capsaicin | 8 | 2009 | 47 | 0.760 |
Why?
|
Myocardial Ischemia | 8 | 2004 | 451 | 0.760 |
Why?
|
Analgesia | 4 | 2019 | 97 | 0.750 |
Why?
|
Protein Transport | 2 | 2021 | 745 | 0.740 |
Why?
|
Electric Stimulation | 14 | 2014 | 442 | 0.730 |
Why?
|
Narcotics | 3 | 2006 | 125 | 0.730 |
Why?
|
Cyclohexanecarboxylic Acids | 5 | 2009 | 42 | 0.720 |
Why?
|
Gene-Environment Interaction | 1 | 2021 | 167 | 0.720 |
Why?
|
Muscarine | 4 | 2018 | 16 | 0.720 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2012 | 175 | 0.710 |
Why?
|
Amines | 5 | 2009 | 84 | 0.710 |
Why?
|
Peripheral Nervous System Diseases | 4 | 2009 | 398 | 0.700 |
Why?
|
Reflex | 7 | 2004 | 69 | 0.680 |
Why?
|
Pressoreceptors | 3 | 2009 | 18 | 0.680 |
Why?
|
TRPA1 Cation Channel | 1 | 2019 | 10 | 0.680 |
Why?
|
N-Methylaspartate | 2 | 2022 | 51 | 0.680 |
Why?
|
Spinal Cord Dorsal Horn | 3 | 2023 | 12 | 0.670 |
Why?
|
Receptors, GABA-A | 3 | 2008 | 80 | 0.670 |
Why?
|
Action Potentials | 12 | 2014 | 585 | 0.660 |
Why?
|
Behavior, Animal | 13 | 2020 | 731 | 0.660 |
Why?
|
Receptors, Opioid, delta | 4 | 2008 | 27 | 0.660 |
Why?
|
Electrophysiological Phenomena | 5 | 2019 | 77 | 0.650 |
Why?
|
Vasomotor System | 2 | 2010 | 31 | 0.650 |
Why?
|
Mice, Inbred C57BL | 11 | 2021 | 7173 | 0.650 |
Why?
|
Organ Culture Techniques | 6 | 2020 | 246 | 0.640 |
Why?
|
Ischemia | 9 | 1997 | 400 | 0.640 |
Why?
|
HEK293 Cells | 7 | 2021 | 1513 | 0.630 |
Why?
|
Spinal Nerve Roots | 4 | 2014 | 66 | 0.630 |
Why?
|
Disease Models, Animal | 20 | 2018 | 7429 | 0.620 |
Why?
|
Physical Stimulation | 10 | 2014 | 115 | 0.620 |
Why?
|
Norepinephrine | 8 | 2023 | 277 | 0.610 |
Why?
|
Gene Expression | 3 | 2013 | 3594 | 0.600 |
Why?
|
Neural Pathways | 8 | 2008 | 311 | 0.600 |
Why?
|
Potassium Channels, Voltage-Gated | 2 | 2010 | 69 | 0.600 |
Why?
|
Renin-Angiotensin System | 1 | 2018 | 109 | 0.600 |
Why?
|
Receptors, Nicotinic | 5 | 2001 | 191 | 0.590 |
Why?
|
Hippocampus | 3 | 2020 | 937 | 0.590 |
Why?
|
Receptors, Adrenergic, alpha-1 | 2 | 2008 | 40 | 0.580 |
Why?
|
Receptor, Cannabinoid, CB2 | 5 | 2020 | 17 | 0.570 |
Why?
|
Kv1.2 Potassium Channel | 2 | 2007 | 18 | 0.570 |
Why?
|
Gene Silencing | 2 | 2020 | 840 | 0.560 |
Why?
|
Microinjections | 6 | 2020 | 93 | 0.560 |
Why?
|
Kv1.1 Potassium Channel | 2 | 2007 | 41 | 0.560 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channels | 2 | 2018 | 34 | 0.560 |
Why?
|
Casein Kinase I | 2 | 2015 | 23 | 0.550 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 189 | 0.550 |
Why?
|
Vestibular Nuclei | 1 | 2016 | 15 | 0.540 |
Why?
|
Receptors, Opioid | 3 | 2022 | 38 | 0.540 |
Why?
|
Nerve Fibers | 7 | 2009 | 116 | 0.540 |
Why?
|
Cats | 20 | 2002 | 166 | 0.540 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2017 | 132 | 0.530 |
Why?
|
Symporters | 2 | 2016 | 105 | 0.520 |
Why?
|
Paclitaxel | 3 | 2023 | 2056 | 0.520 |
Why?
|
Brain Ischemia | 1 | 2018 | 302 | 0.520 |
Why?
|
Calpain | 2 | 2013 | 70 | 0.520 |
Why?
|
Hot Temperature | 6 | 2017 | 283 | 0.520 |
Why?
|
Signal Transduction | 8 | 2014 | 12151 | 0.520 |
Why?
|
Bortezomib | 1 | 2017 | 549 | 0.510 |
Why?
|
Penicillamine | 4 | 2004 | 22 | 0.500 |
Why?
|
Connexins | 1 | 2015 | 81 | 0.500 |
Why?
|
Viscera | 5 | 2001 | 89 | 0.500 |
Why?
|
Baroreflex | 2 | 2009 | 11 | 0.500 |
Why?
|
Neostigmine | 5 | 2004 | 17 | 0.490 |
Why?
|
Locus Coeruleus | 3 | 2004 | 35 | 0.490 |
Why?
|
Adenosine | 4 | 2010 | 294 | 0.490 |
Why?
|
Epigenesis, Genetic | 3 | 2022 | 1432 | 0.490 |
Why?
|
Sciatic Nerve | 6 | 2021 | 115 | 0.490 |
Why?
|
Potassium Channels, Calcium-Activated | 1 | 2014 | 14 | 0.480 |
Why?
|
Receptor, Muscarinic M3 | 4 | 2009 | 21 | 0.480 |
Why?
|
Peptides | 7 | 2022 | 1504 | 0.480 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 886 | 0.470 |
Why?
|
Amygdala | 2 | 2005 | 124 | 0.470 |
Why?
|
Trauma, Nervous System | 1 | 2013 | 11 | 0.460 |
Why?
|
src-Family Kinases | 1 | 2016 | 480 | 0.460 |
Why?
|
Calmodulin | 2 | 2014 | 248 | 0.460 |
Why?
|
Down-Regulation | 5 | 2018 | 2114 | 0.450 |
Why?
|
Neuromuscular Junction | 2 | 2014 | 92 | 0.450 |
Why?
|
Cholinergic Agents | 4 | 2016 | 21 | 0.450 |
Why?
|
Pons | 1 | 2013 | 49 | 0.440 |
Why?
|
Membrane Proteins | 3 | 2020 | 2917 | 0.430 |
Why?
|
Glutamates | 2 | 2020 | 131 | 0.430 |
Why?
|
Sodium-Potassium-Chloride Symporters | 1 | 2012 | 12 | 0.430 |
Why?
|
Tetrodotoxin | 4 | 2014 | 68 | 0.420 |
Why?
|
NFATC Transcription Factors | 1 | 2013 | 102 | 0.420 |
Why?
|
Anticonvulsants | 3 | 2001 | 441 | 0.420 |
Why?
|
Brain Injuries | 1 | 2018 | 752 | 0.410 |
Why?
|
Anesthetics, Local | 3 | 2004 | 171 | 0.410 |
Why?
|
Sciatic Neuropathy | 2 | 2002 | 12 | 0.410 |
Why?
|
Supraoptic Nucleus | 2 | 2001 | 8 | 0.410 |
Why?
|
Oxotremorine | 9 | 2014 | 24 | 0.400 |
Why?
|
S-Nitroso-N-Acetylpenicillamine | 4 | 2017 | 16 | 0.400 |
Why?
|
Cerebellum | 1 | 2016 | 468 | 0.400 |
Why?
|
Blotting, Western | 7 | 2016 | 3596 | 0.400 |
Why?
|
Protein Binding | 7 | 2021 | 3483 | 0.400 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2012 | 69 | 0.390 |
Why?
|
Lectins | 5 | 2010 | 153 | 0.390 |
Why?
|
GABA Agonists | 5 | 2009 | 23 | 0.390 |
Why?
|
Interneurons | 3 | 2007 | 149 | 0.380 |
Why?
|
Calcium Channel Blockers | 5 | 2009 | 135 | 0.380 |
Why?
|
Cholinesterase Inhibitors | 3 | 2004 | 114 | 0.380 |
Why?
|
Oligopeptides | 4 | 2008 | 431 | 0.380 |
Why?
|
Nitric Oxide Donors | 5 | 2007 | 51 | 0.380 |
Why?
|
Baclofen | 5 | 2009 | 50 | 0.370 |
Why?
|
Female | 43 | 2023 | 147292 | 0.370 |
Why?
|
Acetates | 3 | 2000 | 116 | 0.370 |
Why?
|
Pirenzepine | 2 | 2016 | 10 | 0.370 |
Why?
|
Repressor Proteins | 1 | 2018 | 1699 | 0.370 |
Why?
|
RNA, Small Interfering | 4 | 2014 | 2223 | 0.360 |
Why?
|
Somatostatin | 3 | 2006 | 117 | 0.360 |
Why?
|
GTP-Binding Proteins | 4 | 2008 | 325 | 0.360 |
Why?
|
KATP Channels | 1 | 2010 | 12 | 0.360 |
Why?
|
Naltrexone | 3 | 2008 | 96 | 0.360 |
Why?
|
Muscarinic Antagonists | 9 | 2006 | 85 | 0.360 |
Why?
|
Glycine Agents | 2 | 2008 | 14 | 0.350 |
Why?
|
Touch | 4 | 2017 | 70 | 0.350 |
Why?
|
Yohimbine | 4 | 2023 | 28 | 0.350 |
Why?
|
Electroacupuncture | 5 | 2013 | 35 | 0.350 |
Why?
|
Antineoplastic Agents | 3 | 2023 | 14506 | 0.340 |
Why?
|
Stroke | 1 | 2018 | 1199 | 0.340 |
Why?
|
Infarction, Middle Cerebral Artery | 2 | 2020 | 44 | 0.340 |
Why?
|
RNA, Messenger | 6 | 2023 | 6224 | 0.340 |
Why?
|
Ion Channel Gating | 5 | 2011 | 151 | 0.340 |
Why?
|
Aminobutyrates | 2 | 2008 | 16 | 0.330 |
Why?
|
Cells, Cultured | 6 | 2020 | 5670 | 0.320 |
Why?
|
Synaptophysin | 5 | 2007 | 79 | 0.320 |
Why?
|
Neuroprotective Agents | 2 | 2018 | 217 | 0.310 |
Why?
|
Neuralgia, Postherpetic | 2 | 2021 | 8 | 0.310 |
Why?
|
Digestive System | 3 | 1997 | 115 | 0.310 |
Why?
|
Histones | 3 | 2022 | 1493 | 0.310 |
Why?
|
Cardiovascular Physiological Phenomena | 3 | 2001 | 44 | 0.310 |
Why?
|
Nitric Oxide Synthase Type I | 4 | 2017 | 56 | 0.310 |
Why?
|
Reaction Time | 6 | 2006 | 236 | 0.300 |
Why?
|
Transcription, Genetic | 1 | 2016 | 3148 | 0.300 |
Why?
|
Inflammation | 6 | 2022 | 2572 | 0.300 |
Why?
|
Cyclic GMP | 3 | 2017 | 125 | 0.300 |
Why?
|
Nerve Tissue Proteins | 1 | 2015 | 1508 | 0.290 |
Why?
|
Tissue Culture Techniques | 2 | 2017 | 115 | 0.290 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2007 | 480 | 0.290 |
Why?
|
Enzyme Inhibitors | 9 | 2008 | 1937 | 0.290 |
Why?
|
Gene Expression Regulation | 7 | 2016 | 4071 | 0.290 |
Why?
|
Drug Delivery Systems | 1 | 2011 | 683 | 0.280 |
Why?
|
Promoter Regions, Genetic | 3 | 2020 | 3109 | 0.280 |
Why?
|
Benzodiazepines | 2 | 2011 | 178 | 0.280 |
Why?
|
Isoenzymes | 2 | 2017 | 633 | 0.270 |
Why?
|
Receptors, GABA | 1 | 2005 | 19 | 0.270 |
Why?
|
Receptors, Purinergic P1 | 3 | 2003 | 25 | 0.270 |
Why?
|
Guanosine Diphosphate | 3 | 2010 | 27 | 0.260 |
Why?
|
Nerve Fibers, Myelinated | 3 | 2003 | 125 | 0.260 |
Why?
|
Thionucleotides | 3 | 2010 | 64 | 0.260 |
Why?
|
Parasympathetic Nervous System | 1 | 2005 | 27 | 0.260 |
Why?
|
Biophysics | 3 | 2010 | 112 | 0.250 |
Why?
|
Periaqueductal Gray | 1 | 2004 | 13 | 0.250 |
Why?
|
Calcium Channels, Q-Type | 1 | 2004 | 9 | 0.250 |
Why?
|
Calcium Channels, P-Type | 1 | 2004 | 10 | 0.250 |
Why?
|
Egtazic Acid | 4 | 2010 | 54 | 0.250 |
Why?
|
Nitric Oxide Synthase | 6 | 2003 | 322 | 0.240 |
Why?
|
Analysis of Variance | 6 | 2014 | 2327 | 0.240 |
Why?
|
Angina Pectoris | 1 | 2004 | 90 | 0.240 |
Why?
|
Substantia Gelatinosa | 1 | 2004 | 3 | 0.240 |
Why?
|
Miniature Postsynaptic Potentials | 2 | 2014 | 8 | 0.240 |
Why?
|
Phosphinic Acids | 3 | 2008 | 5 | 0.230 |
Why?
|
Sodium Channels | 1 | 2004 | 115 | 0.230 |
Why?
|
S-Nitrosothiols | 2 | 2000 | 7 | 0.230 |
Why?
|
Splanchnic Nerves | 3 | 2001 | 14 | 0.220 |
Why?
|
Ethylmaleimide | 2 | 2017 | 14 | 0.220 |
Why?
|
Duloxetine Hydrochloride | 1 | 2023 | 17 | 0.220 |
Why?
|
Receptors, Glycine | 2 | 2014 | 22 | 0.220 |
Why?
|
Abdomen | 5 | 1997 | 338 | 0.220 |
Why?
|
Fentanyl | 2 | 2019 | 154 | 0.220 |
Why?
|
Pericardium | 1 | 2004 | 161 | 0.220 |
Why?
|
Aspartic Acid | 1 | 2023 | 127 | 0.220 |
Why?
|
Chelating Agents | 3 | 2010 | 131 | 0.220 |
Why?
|
Receptors, Adrenergic | 1 | 2023 | 50 | 0.220 |
Why?
|
Dichlororibofuranosylbenzimidazole | 2 | 2014 | 12 | 0.220 |
Why?
|
Gallbladder | 4 | 2001 | 70 | 0.220 |
Why?
|
Muscimol | 3 | 2008 | 13 | 0.220 |
Why?
|
Fluorescent Antibody Technique | 5 | 2010 | 1079 | 0.220 |
Why?
|
Histone Deacetylase 2 | 1 | 2022 | 36 | 0.210 |
Why?
|
Adrenergic alpha-Antagonists | 5 | 2008 | 71 | 0.210 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2022 | 8 | 0.210 |
Why?
|
Immunohistochemistry | 8 | 2006 | 7704 | 0.210 |
Why?
|
Nucleus Accumbens | 1 | 2022 | 63 | 0.210 |
Why?
|
Atropine | 5 | 2005 | 48 | 0.210 |
Why?
|
Spinothalamic Tracts | 1 | 2002 | 19 | 0.210 |
Why?
|
Soluble Guanylyl Cyclase | 2 | 2017 | 16 | 0.210 |
Why?
|
Guanosine 5'-O-(3-Thiotriphosphate) | 3 | 2009 | 38 | 0.210 |
Why?
|
Receptors, Adrenergic, alpha | 1 | 2002 | 15 | 0.210 |
Why?
|
Ganglionectomy | 2 | 2012 | 4 | 0.210 |
Why?
|
Valine | 3 | 2014 | 183 | 0.200 |
Why?
|
Cysteine | 2 | 2000 | 214 | 0.200 |
Why?
|
Mice, Transgenic | 4 | 2018 | 4245 | 0.200 |
Why?
|
Tritium | 3 | 2008 | 206 | 0.200 |
Why?
|
Solitary Nucleus | 1 | 2001 | 8 | 0.200 |
Why?
|
Carbazoles | 2 | 2013 | 88 | 0.200 |
Why?
|
Organophosphorus Compounds | 1 | 2002 | 104 | 0.200 |
Why?
|
Receptors, Bradykinin | 3 | 1998 | 5 | 0.200 |
Why?
|
Blood Circulation | 1 | 2001 | 32 | 0.200 |
Why?
|
Gene Products, tat | 1 | 2021 | 60 | 0.190 |
Why?
|
Histone Code | 1 | 2022 | 83 | 0.190 |
Why?
|
Potassium Channels, Inwardly Rectifying | 2 | 2014 | 46 | 0.190 |
Why?
|
Nerve Net | 1 | 2004 | 270 | 0.190 |
Why?
|
Memantine | 2 | 2013 | 49 | 0.190 |
Why?
|
Cell Membrane Permeability | 1 | 2021 | 125 | 0.190 |
Why?
|
Neurotoxins | 1 | 2021 | 66 | 0.190 |
Why?
|
KCNQ Potassium Channels | 2 | 2014 | 11 | 0.190 |
Why?
|
Narcotic Antagonists | 3 | 2008 | 140 | 0.180 |
Why?
|
Nestin | 1 | 2020 | 45 | 0.180 |
Why?
|
Injections, Intravenous | 5 | 2005 | 578 | 0.180 |
Why?
|
Ligation | 4 | 2009 | 193 | 0.180 |
Why?
|
Skin | 3 | 2011 | 1284 | 0.180 |
Why?
|
Ischemic Preconditioning | 1 | 2000 | 20 | 0.180 |
Why?
|
Brain | 2 | 2023 | 4194 | 0.180 |
Why?
|
Propionates | 1 | 2020 | 76 | 0.180 |
Why?
|
Mercaptoethanol | 1 | 2000 | 18 | 0.180 |
Why?
|
Nerve Tissue | 1 | 2020 | 10 | 0.180 |
Why?
|
Heart Conduction System | 3 | 1996 | 169 | 0.180 |
Why?
|
Real-Time Polymerase Chain Reaction | 3 | 2013 | 1233 | 0.180 |
Why?
|
Antidepressive Agents | 1 | 2023 | 342 | 0.180 |
Why?
|
Membrane Transport Proteins | 1 | 2001 | 248 | 0.170 |
Why?
|
Cell Membrane | 2 | 2014 | 861 | 0.170 |
Why?
|
Hypoxia | 2 | 2020 | 456 | 0.170 |
Why?
|
Humans | 23 | 2022 | 270843 | 0.170 |
Why?
|
Brain Stem | 3 | 2014 | 177 | 0.170 |
Why?
|
Endoplasmic Reticulum | 1 | 2021 | 318 | 0.170 |
Why?
|
CA1 Region, Hippocampal | 1 | 2020 | 76 | 0.170 |
Why?
|
Permeability | 1 | 2019 | 171 | 0.170 |
Why?
|
Phosphorylation | 2 | 2021 | 4887 | 0.170 |
Why?
|
Pyridazines | 2 | 2016 | 306 | 0.170 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 225 | 0.170 |
Why?
|
omega-Conotoxin GVIA | 2 | 2009 | 10 | 0.160 |
Why?
|
Tetrazolium Salts | 1 | 2018 | 54 | 0.160 |
Why?
|
Biophysical Phenomena | 2 | 2008 | 113 | 0.160 |
Why?
|
Microscopy, Confocal | 4 | 2010 | 676 | 0.160 |
Why?
|
Flagella | 1 | 2018 | 38 | 0.160 |
Why?
|
Propanolamines | 2 | 2008 | 46 | 0.160 |
Why?
|
Alkenes | 2 | 2016 | 12 | 0.160 |
Why?
|
Versicans | 2 | 2008 | 32 | 0.160 |
Why?
|
Arginine | 2 | 2017 | 518 | 0.160 |
Why?
|
Nicotinic Antagonists | 4 | 2001 | 17 | 0.160 |
Why?
|
Methylation | 1 | 2020 | 599 | 0.160 |
Why?
|
Cyclic GMP-Dependent Protein Kinases | 2 | 2011 | 24 | 0.160 |
Why?
|
Chest Pain | 1 | 1999 | 171 | 0.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 3666 | 0.150 |
Why?
|
Time Factors | 8 | 2013 | 13266 | 0.150 |
Why?
|
Benzoates | 2 | 2014 | 133 | 0.150 |
Why?
|
Guanylate Cyclase | 2 | 2011 | 76 | 0.150 |
Why?
|
Piperidines | 5 | 2016 | 1067 | 0.150 |
Why?
|
Central Nervous System Agents | 1 | 2017 | 19 | 0.150 |
Why?
|
Lysine | 1 | 2020 | 428 | 0.150 |
Why?
|
Gene Knockout Techniques | 1 | 2018 | 278 | 0.150 |
Why?
|
Bupivacaine | 1 | 1998 | 67 | 0.150 |
Why?
|
Triazoles | 2 | 2014 | 630 | 0.150 |
Why?
|
Neuropeptide Y | 1 | 2017 | 46 | 0.150 |
Why?
|
Receptors, Ghrelin | 1 | 2017 | 35 | 0.150 |
Why?
|
Naloxone | 2 | 2008 | 85 | 0.150 |
Why?
|
Ghrelin | 1 | 2017 | 78 | 0.140 |
Why?
|
Xanthines | 2 | 2010 | 30 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 5716 | 0.140 |
Why?
|
Protons | 1 | 1999 | 476 | 0.140 |
Why?
|
Leukotriene B4 | 2 | 1995 | 20 | 0.140 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2016 | 11 | 0.140 |
Why?
|
Synaptosomes | 3 | 2000 | 38 | 0.140 |
Why?
|
Kynurenic Acid | 2 | 2007 | 25 | 0.130 |
Why?
|
Kidney | 4 | 2009 | 2200 | 0.130 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2019 | 734 | 0.130 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2016 | 89 | 0.130 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2008 | 745 | 0.130 |
Why?
|
DNA | 1 | 2023 | 2745 | 0.130 |
Why?
|
Infertility, Male | 1 | 2018 | 306 | 0.130 |
Why?
|
Receptors, Neurokinin-1 | 1 | 1995 | 31 | 0.130 |
Why?
|
Transduction, Genetic | 1 | 2016 | 470 | 0.120 |
Why?
|
2-Amino-5-phosphonovalerate | 2 | 2007 | 25 | 0.120 |
Why?
|
Amino Acid Motifs | 1 | 2015 | 412 | 0.120 |
Why?
|
Gene Deletion | 1 | 2020 | 1476 | 0.120 |
Why?
|
Glycoproteins | 2 | 2008 | 763 | 0.120 |
Why?
|
Tubulin Modulators | 1 | 2014 | 65 | 0.120 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2015 | 620 | 0.120 |
Why?
|
Glyburide | 2 | 2014 | 29 | 0.120 |
Why?
|
Death, Sudden | 1 | 2014 | 59 | 0.120 |
Why?
|
Sodium Channel Blockers | 2 | 2014 | 37 | 0.120 |
Why?
|
Glucose | 1 | 2020 | 1267 | 0.120 |
Why?
|
Stress, Psychological | 1 | 2021 | 1035 | 0.120 |
Why?
|
Endosomes | 1 | 2014 | 110 | 0.120 |
Why?
|
Physical Exertion | 1 | 1993 | 117 | 0.110 |
Why?
|
Dopamine beta-Hydroxylase | 2 | 2004 | 39 | 0.110 |
Why?
|
Microtubules | 1 | 2014 | 267 | 0.110 |
Why?
|
Rotarod Performance Test | 1 | 2013 | 25 | 0.110 |
Why?
|
Cysteine Endopeptidases | 1 | 2014 | 255 | 0.110 |
Why?
|
Mechanoreceptors | 2 | 2005 | 28 | 0.110 |
Why?
|
Hemodynamics | 4 | 2001 | 1005 | 0.110 |
Why?
|
Keratinocytes | 2 | 2011 | 244 | 0.110 |
Why?
|
Coronary Vessels | 5 | 2001 | 692 | 0.110 |
Why?
|
Cyclopropanes | 1 | 2013 | 90 | 0.110 |
Why?
|
Peptide Fragments | 3 | 2006 | 1294 | 0.110 |
Why?
|
Ganglia, Sympathetic | 1 | 2012 | 32 | 0.110 |
Why?
|
Synaptic Potentials | 1 | 2012 | 16 | 0.100 |
Why?
|
Pyridines | 2 | 2014 | 1291 | 0.100 |
Why?
|
beta-Endorphin | 1 | 2011 | 42 | 0.100 |
Why?
|
Glycosylation | 1 | 2012 | 219 | 0.100 |
Why?
|
Mecamylamine | 2 | 2001 | 15 | 0.100 |
Why?
|
Nitrosation | 1 | 2011 | 10 | 0.100 |
Why?
|
Radioligand Assay | 2 | 2009 | 53 | 0.100 |
Why?
|
Cannabidiol | 1 | 2012 | 42 | 0.100 |
Why?
|
Stress, Mechanical | 2 | 2003 | 317 | 0.100 |
Why?
|
Injections, Intraventricular | 1 | 2011 | 114 | 0.100 |
Why?
|
Temperature | 1 | 2013 | 522 | 0.100 |
Why?
|
Intracellular Space | 2 | 2011 | 77 | 0.100 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 365 | 0.100 |
Why?
|
Circadian Clocks | 1 | 2011 | 66 | 0.100 |
Why?
|
Biological Transport | 1 | 2012 | 605 | 0.090 |
Why?
|
Indole Alkaloids | 1 | 2010 | 7 | 0.090 |
Why?
|
Nickel | 2 | 2008 | 42 | 0.090 |
Why?
|
Nitroso Compounds | 2 | 2000 | 17 | 0.090 |
Why?
|
Dizocilpine Maleate | 1 | 2010 | 22 | 0.090 |
Why?
|
Receptor, trkB | 1 | 2010 | 53 | 0.090 |
Why?
|
Tolbutamide | 1 | 2010 | 10 | 0.090 |
Why?
|
Pertussis Toxin | 2 | 2007 | 59 | 0.090 |
Why?
|
Receptor, Adenosine A1 | 1 | 2010 | 6 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2011 | 214 | 0.090 |
Why?
|
Deferoxamine | 3 | 2007 | 28 | 0.090 |
Why?
|
Nodose Ganglion | 1 | 2009 | 6 | 0.090 |
Why?
|
Chromones | 1 | 2009 | 120 | 0.090 |
Why?
|
Phenotype | 1 | 2021 | 6404 | 0.090 |
Why?
|
Cell Line | 3 | 2012 | 5132 | 0.090 |
Why?
|
Arachidonic Acids | 1 | 2009 | 30 | 0.080 |
Why?
|
Polyunsaturated Alkamides | 1 | 2009 | 35 | 0.080 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2009 | 29 | 0.080 |
Why?
|
Prefrontal Cortex | 1 | 2011 | 237 | 0.080 |
Why?
|
Mibefradil | 1 | 2008 | 3 | 0.080 |
Why?
|
Stimulation, Chemical | 2 | 2002 | 96 | 0.080 |
Why?
|
Picrotoxin | 1 | 2008 | 20 | 0.080 |
Why?
|
Dioxanes | 1 | 2008 | 11 | 0.080 |
Why?
|
Strychnine | 1 | 2008 | 8 | 0.080 |
Why?
|
Cyclopentanes | 1 | 2009 | 45 | 0.080 |
Why?
|
Triazines | 1 | 2010 | 118 | 0.080 |
Why?
|
Amiloride | 1 | 2008 | 47 | 0.080 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2008 | 27 | 0.080 |
Why?
|
Anthracenes | 1 | 2008 | 48 | 0.080 |
Why?
|
Phenylephrine | 1 | 2008 | 49 | 0.080 |
Why?
|
Chitosan | 1 | 2009 | 84 | 0.080 |
Why?
|
Lactic Acid | 2 | 2002 | 310 | 0.080 |
Why?
|
Indomethacin | 3 | 2000 | 94 | 0.080 |
Why?
|
Peripheral Nerves | 2 | 2000 | 162 | 0.080 |
Why?
|
Catecholamines | 1 | 1989 | 100 | 0.080 |
Why?
|
Cadmium | 1 | 2008 | 51 | 0.080 |
Why?
|
Motor Activity | 1 | 2013 | 694 | 0.080 |
Why?
|
Pain Management | 2 | 2009 | 703 | 0.080 |
Why?
|
Hypokalemia | 1 | 1989 | 57 | 0.080 |
Why?
|
Rhizotomy | 1 | 2008 | 23 | 0.080 |
Why?
|
Vasoconstrictor Agents | 1 | 2009 | 157 | 0.080 |
Why?
|
Myasthenia Gravis | 1 | 2009 | 97 | 0.080 |
Why?
|
Seizures | 1 | 2014 | 999 | 0.080 |
Why?
|
Biocompatible Materials | 1 | 2009 | 209 | 0.080 |
Why?
|
Receptors, Neurotransmitter | 1 | 2008 | 30 | 0.080 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 4281 | 0.080 |
Why?
|
Splanchnic Circulation | 2 | 2001 | 59 | 0.080 |
Why?
|
Cyclic ADP-Ribose | 1 | 2007 | 4 | 0.080 |
Why?
|
Benzimidazoles | 1 | 2011 | 438 | 0.080 |
Why?
|
Vasodilator Agents | 1 | 2009 | 234 | 0.080 |
Why?
|
Flavanones | 1 | 2007 | 11 | 0.070 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 2007 | 21 | 0.070 |
Why?
|
Thapsigargin | 1 | 2007 | 41 | 0.070 |
Why?
|
Arachidonate 12-Lipoxygenase | 1 | 2007 | 18 | 0.070 |
Why?
|
Eating | 2 | 2017 | 431 | 0.070 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2007 | 195 | 0.070 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 6127 | 0.070 |
Why?
|
Metalloporphyrins | 1 | 2007 | 32 | 0.070 |
Why?
|
Extracellular Space | 1 | 2007 | 134 | 0.070 |
Why?
|
Laminectomy | 1 | 2007 | 52 | 0.070 |
Why?
|
Bradykinin Receptor Antagonists | 3 | 1998 | 3 | 0.070 |
Why?
|
GABA Modulators | 1 | 2006 | 15 | 0.070 |
Why?
|
Diazepam | 1 | 2006 | 42 | 0.070 |
Why?
|
Cadmium Chloride | 1 | 2006 | 4 | 0.070 |
Why?
|
Staining and Labeling | 1 | 2008 | 431 | 0.070 |
Why?
|
Myocardial Infarction | 3 | 1995 | 1498 | 0.070 |
Why?
|
Sulfur Radioisotopes | 2 | 2003 | 27 | 0.070 |
Why?
|
Aryldialkylphosphatase | 1 | 2006 | 12 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 1792 | 0.070 |
Why?
|
Benzylamines | 1 | 2006 | 103 | 0.070 |
Why?
|
Sulfur Isotopes | 1 | 2006 | 3 | 0.070 |
Why?
|
Glutamine | 1 | 2008 | 303 | 0.070 |
Why?
|
Myocardium | 3 | 2003 | 1335 | 0.070 |
Why?
|
Spinal Cord Injuries | 1 | 2009 | 340 | 0.070 |
Why?
|
Glycine Plasma Membrane Transport Proteins | 1 | 2006 | 7 | 0.070 |
Why?
|
Elapid Venoms | 1 | 2005 | 11 | 0.070 |
Why?
|
Animals, Newborn | 2 | 2014 | 1350 | 0.070 |
Why?
|
Scorpion Venoms | 1 | 2005 | 15 | 0.070 |
Why?
|
Adrenergic Antagonists | 1 | 2005 | 19 | 0.070 |
Why?
|
Limbic System | 1 | 2005 | 30 | 0.070 |
Why?
|
Microdialysis | 3 | 2000 | 52 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2009 | 367 | 0.070 |
Why?
|
Adrenergic alpha-1 Receptor Antagonists | 1 | 2005 | 29 | 0.070 |
Why?
|
Portal Vein | 2 | 2001 | 365 | 0.070 |
Why?
|
Nerve Degeneration | 1 | 2007 | 152 | 0.070 |
Why?
|
Imidazoles | 2 | 2003 | 1029 | 0.060 |
Why?
|
Tetraethylammonium | 1 | 2005 | 15 | 0.060 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2005 | 19 | 0.060 |
Why?
|
Base Sequence | 1 | 2011 | 4932 | 0.060 |
Why?
|
Ruthenium Red | 1 | 2004 | 6 | 0.060 |
Why?
|
Protein Phosphatase 1 | 1 | 2005 | 77 | 0.060 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 496 | 0.060 |
Why?
|
Administration, Topical | 1 | 2005 | 266 | 0.060 |
Why?
|
DNA Methylation | 1 | 2015 | 2736 | 0.060 |
Why?
|
Ferrets | 1 | 2004 | 25 | 0.060 |
Why?
|
Protein Phosphatase 2 | 1 | 2005 | 88 | 0.060 |
Why?
|
Hindlimb | 3 | 2009 | 110 | 0.060 |
Why?
|
Cell Size | 1 | 2004 | 147 | 0.060 |
Why?
|
GABA-B Receptor Antagonists | 1 | 2004 | 2 | 0.060 |
Why?
|
Carbocyanines | 1 | 2004 | 40 | 0.060 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2004 | 36 | 0.060 |
Why?
|
Tryptophan Hydroxylase | 1 | 2004 | 27 | 0.060 |
Why?
|
Disease Progression | 1 | 2015 | 6891 | 0.060 |
Why?
|
Pro-Opiomelanocortin | 2 | 2017 | 109 | 0.060 |
Why?
|
Receptors, Angiotensin | 1 | 2003 | 45 | 0.060 |
Why?
|
Losartan | 1 | 2003 | 47 | 0.060 |
Why?
|
Neural Conduction | 3 | 2002 | 112 | 0.060 |
Why?
|
omega-N-Methylarginine | 1 | 2003 | 35 | 0.060 |
Why?
|
Autoradiography | 1 | 2002 | 133 | 0.050 |
Why?
|
Evoked Potentials | 1 | 2004 | 196 | 0.050 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2003 | 46 | 0.050 |
Why?
|
Reference Values | 3 | 2000 | 1129 | 0.050 |
Why?
|
Prazosin | 1 | 2002 | 22 | 0.050 |
Why?
|
Visceral Afferents | 1 | 2002 | 8 | 0.050 |
Why?
|
Young Adult | 1 | 2021 | 22140 | 0.050 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2002 | 63 | 0.050 |
Why?
|
Drinking | 1 | 2002 | 54 | 0.050 |
Why?
|
Carboxypeptidases | 1 | 2002 | 26 | 0.050 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2002 | 16 | 0.050 |
Why?
|
Tibial Nerve | 1 | 2002 | 18 | 0.050 |
Why?
|
Receptors, Opioid, kappa | 1 | 2002 | 32 | 0.050 |
Why?
|
Dinoprostone | 2 | 2012 | 214 | 0.050 |
Why?
|
Pregabalin | 1 | 2001 | 8 | 0.050 |
Why?
|
Thiophenes | 1 | 2003 | 151 | 0.050 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2003 | 156 | 0.050 |
Why?
|
Instillation, Drug | 1 | 2001 | 16 | 0.050 |
Why?
|
Hemicholinium 3 | 1 | 2001 | 4 | 0.050 |
Why?
|
Purinergic P1 Receptor Antagonists | 1 | 2001 | 4 | 0.050 |
Why?
|
Purinergic P1 Receptor Agonists | 1 | 2001 | 6 | 0.050 |
Why?
|
Aziridines | 1 | 2001 | 18 | 0.050 |
Why?
|
Binding Sites | 2 | 2003 | 2210 | 0.050 |
Why?
|
Neurons, Efferent | 1 | 2001 | 6 | 0.050 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2002 | 277 | 0.050 |
Why?
|
Stereoisomerism | 1 | 2001 | 175 | 0.050 |
Why?
|
Microtubule-Associated Proteins | 1 | 2004 | 530 | 0.050 |
Why?
|
Endothelin-1 | 1 | 2001 | 64 | 0.050 |
Why?
|
Injections, Intraperitoneal | 1 | 2001 | 200 | 0.050 |
Why?
|
Celiac Artery | 1 | 2001 | 40 | 0.050 |
Why?
|
Aspirin | 2 | 1995 | 473 | 0.050 |
Why?
|
Choline | 1 | 2001 | 76 | 0.050 |
Why?
|
Mesenteric Arteries | 1 | 2001 | 57 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2002 | 616 | 0.050 |
Why?
|
Vagotomy | 1 | 2000 | 26 | 0.050 |
Why?
|
Stellate Ganglion | 1 | 2000 | 15 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2652 | 0.050 |
Why?
|
Microelectrodes | 1 | 2000 | 52 | 0.050 |
Why?
|
Drug Administration Routes | 1 | 2000 | 62 | 0.050 |
Why?
|
Amino Acids, Cyclic | 1 | 2000 | 1 | 0.050 |
Why?
|
Vascular Resistance | 1 | 2001 | 205 | 0.050 |
Why?
|
Endocardium | 1 | 2000 | 50 | 0.050 |
Why?
|
Lidocaine | 1 | 2000 | 78 | 0.050 |
Why?
|
Adolescent | 1 | 2021 | 32336 | 0.050 |
Why?
|
Nitrites | 1 | 2000 | 62 | 0.040 |
Why?
|
Bile Ducts | 2 | 1997 | 113 | 0.040 |
Why?
|
Kinetics | 1 | 2003 | 2098 | 0.040 |
Why?
|
Buffers | 1 | 1999 | 44 | 0.040 |
Why?
|
Cyclooxygenase 1 | 1 | 2000 | 68 | 0.040 |
Why?
|
Hypercapnia | 1 | 1999 | 28 | 0.040 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 1999 | 34 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 599 | 0.040 |
Why?
|
Acid-Base Equilibrium | 1 | 1999 | 76 | 0.040 |
Why?
|
Electrodes | 1 | 1999 | 117 | 0.040 |
Why?
|
Indans | 1 | 1999 | 71 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2012 | 553 | 0.040 |
Why?
|
Perforant Pathway | 1 | 2018 | 15 | 0.040 |
Why?
|
Thalamus | 1 | 2000 | 137 | 0.040 |
Why?
|
Anions | 1 | 2018 | 40 | 0.040 |
Why?
|
Parasympathomimetics | 1 | 1998 | 8 | 0.040 |
Why?
|
Sympathectomy | 1 | 1998 | 15 | 0.040 |
Why?
|
Exploratory Behavior | 1 | 1999 | 106 | 0.040 |
Why?
|
Hydroxyl Radical | 2 | 1995 | 20 | 0.040 |
Why?
|
Ion Transport | 1 | 2018 | 74 | 0.040 |
Why?
|
Biological Transport, Active | 1 | 2018 | 133 | 0.040 |
Why?
|
Myocardial Reperfusion | 2 | 1995 | 112 | 0.040 |
Why?
|
Alkaloids | 2 | 2010 | 80 | 0.040 |
Why?
|
Median Nerve | 1 | 1998 | 24 | 0.040 |
Why?
|
Blood Gas Analysis | 2 | 1999 | 103 | 0.040 |
Why?
|
Dentate Gyrus | 1 | 2018 | 56 | 0.040 |
Why?
|
Receptors, Histamine H1 | 1 | 1997 | 7 | 0.040 |
Why?
|
Histamine H1 Antagonists | 1 | 1997 | 25 | 0.040 |
Why?
|
Furans | 2 | 2010 | 106 | 0.040 |
Why?
|
Naphthalenes | 2 | 2010 | 84 | 0.040 |
Why?
|
Healthy Volunteers | 1 | 2018 | 190 | 0.040 |
Why?
|
Sperm Motility | 1 | 2018 | 108 | 0.040 |
Why?
|
Gyrus Cinguli | 1 | 2000 | 162 | 0.040 |
Why?
|
Histamine | 1 | 1997 | 57 | 0.040 |
Why?
|
Cyclooxygenase 2 | 1 | 2000 | 494 | 0.040 |
Why?
|
Hydrogen Peroxide | 2 | 1995 | 223 | 0.040 |
Why?
|
Agouti-Related Protein | 1 | 2017 | 51 | 0.040 |
Why?
|
Adult | 2 | 2021 | 80709 | 0.040 |
Why?
|
Arcuate Nucleus of Hypothalamus | 1 | 2017 | 49 | 0.040 |
Why?
|
Software | 1 | 2004 | 1355 | 0.040 |
Why?
|
Uterus | 1 | 2002 | 700 | 0.040 |
Why?
|
Models, Biological | 1 | 2006 | 3255 | 0.040 |
Why?
|
Coronary Circulation | 2 | 1995 | 270 | 0.040 |
Why?
|
China | 1 | 2018 | 626 | 0.040 |
Why?
|
Pancreas | 2 | 1997 | 735 | 0.030 |
Why?
|
Digestive System Physiological Phenomena | 1 | 1996 | 10 | 0.030 |
Why?
|
Drug Synergism | 1 | 2000 | 1337 | 0.030 |
Why?
|
Gastrointestinal Motility | 1 | 1997 | 94 | 0.030 |
Why?
|
Spermatozoa | 1 | 2018 | 319 | 0.030 |
Why?
|
Mesentery | 1 | 1996 | 73 | 0.030 |
Why?
|
Drug Combinations | 1 | 1998 | 635 | 0.030 |
Why?
|
Naphthaleneacetic Acids | 1 | 1995 | 1 | 0.030 |
Why?
|
Aminophylline | 1 | 1995 | 10 | 0.030 |
Why?
|
Lipoxygenase | 1 | 1995 | 26 | 0.030 |
Why?
|
Dipyridamole | 1 | 1995 | 40 | 0.030 |
Why?
|
Neurokinin A | 1 | 1995 | 4 | 0.030 |
Why?
|
Neurokinin-1 Receptor Antagonists | 1 | 1995 | 18 | 0.030 |
Why?
|
Captopril | 1 | 1994 | 35 | 0.030 |
Why?
|
Complement C5a | 1 | 1995 | 36 | 0.030 |
Why?
|
Substance P | 1 | 1995 | 72 | 0.030 |
Why?
|
Lymph | 1 | 1994 | 74 | 0.030 |
Why?
|
Pinacidil | 1 | 2014 | 2 | 0.030 |
Why?
|
Membrane Transport Modulators | 1 | 2014 | 9 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2000 | 642 | 0.030 |
Why?
|
Acoustic Stimulation | 1 | 2014 | 119 | 0.030 |
Why?
|
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | 1 | 1993 | 1 | 0.030 |
Why?
|
Testis | 1 | 2018 | 739 | 0.030 |
Why?
|
Mice, Neurologic Mutants | 1 | 2014 | 80 | 0.030 |
Why?
|
Prostaglandin Antagonists | 1 | 1993 | 6 | 0.030 |
Why?
|
Stiff-Person Syndrome | 1 | 2014 | 11 | 0.030 |
Why?
|
Epoprostenol | 1 | 1994 | 79 | 0.030 |
Why?
|
Cholera Toxin | 1 | 2013 | 61 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2014 | 590 | 0.030 |
Why?
|
Myocardial Reperfusion Injury | 1 | 1995 | 202 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2001 | 2055 | 0.030 |
Why?
|
Muscle Contraction | 1 | 1993 | 226 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2018 | 2943 | 0.030 |
Why?
|
Neutrophils | 2 | 1995 | 845 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2014 | 573 | 0.030 |
Why?
|
Muscles | 1 | 1993 | 423 | 0.030 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2012 | 72 | 0.030 |
Why?
|
Molecular Structure | 1 | 2013 | 539 | 0.030 |
Why?
|
Myelin Sheath | 1 | 2013 | 159 | 0.030 |
Why?
|
Cell Survival | 1 | 2018 | 3062 | 0.030 |
Why?
|
Quinolines | 1 | 1995 | 396 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2013 | 965 | 0.020 |
Why?
|
Parasympatholytics | 1 | 2010 | 11 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2012 | 639 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2011 | 369 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 749 | 0.020 |
Why?
|
Idazoxan | 2 | 2000 | 4 | 0.020 |
Why?
|
Electroencephalography | 1 | 2014 | 937 | 0.020 |
Why?
|
Freund's Adjuvant | 1 | 2009 | 42 | 0.020 |
Why?
|
Endocannabinoids | 1 | 2009 | 24 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 1506 | 0.020 |
Why?
|
Sodium | 2 | 2000 | 354 | 0.020 |
Why?
|
Models, Molecular | 1 | 2013 | 1769 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2018 | 6245 | 0.020 |
Why?
|
Leucine | 2 | 2000 | 362 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 1993 | 1005 | 0.020 |
Why?
|
Sheep | 2 | 1999 | 266 | 0.020 |
Why?
|
Electrocardiography | 1 | 2014 | 1227 | 0.020 |
Why?
|
Potassium | 1 | 1989 | 331 | 0.020 |
Why?
|
Epinephrine | 1 | 1989 | 256 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2009 | 570 | 0.020 |
Why?
|
Rabbits | 1 | 1989 | 978 | 0.020 |
Why?
|
Liver | 1 | 1997 | 2990 | 0.020 |
Why?
|
Regional Blood Flow | 2 | 1999 | 280 | 0.020 |
Why?
|
Biomarkers | 1 | 2018 | 5176 | 0.020 |
Why?
|
Mutation | 2 | 2018 | 15642 | 0.020 |
Why?
|
Thiourea | 2 | 1995 | 18 | 0.020 |
Why?
|
Superoxides | 2 | 1995 | 217 | 0.010 |
Why?
|
Peroxidase | 2 | 1995 | 132 | 0.010 |
Why?
|
Indoles | 1 | 2009 | 1021 | 0.010 |
Why?
|
Macrophages | 1 | 2010 | 1372 | 0.010 |
Why?
|
Carrageenan | 1 | 2003 | 15 | 0.010 |
Why?
|
Dilatation | 1 | 2002 | 85 | 0.010 |
Why?
|
Receptor, Endothelin A | 1 | 2001 | 20 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1995 | 4452 | 0.010 |
Why?
|
Endothelin Receptor Antagonists | 1 | 2001 | 25 | 0.010 |
Why?
|
Sodium Chloride | 1 | 2002 | 156 | 0.010 |
Why?
|
Electromyography | 1 | 2002 | 235 | 0.010 |
Why?
|
Guanosine Triphosphate | 1 | 2001 | 95 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2001 | 345 | 0.010 |
Why?
|
Nomifensine | 1 | 2000 | 1 | 0.010 |
Why?
|
omega-Conotoxins | 1 | 2000 | 7 | 0.010 |
Why?
|
Desipramine | 1 | 2000 | 30 | 0.010 |
Why?
|
Peptides, Cyclic | 1 | 2001 | 138 | 0.010 |
Why?
|
Potassium Chloride | 1 | 2000 | 55 | 0.010 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2000 | 32 | 0.010 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2000 | 45 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2000 | 301 | 0.010 |
Why?
|
Cervix Uteri | 1 | 2002 | 254 | 0.010 |
Why?
|
Pyrazoles | 1 | 2009 | 1523 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2003 | 1410 | 0.010 |
Why?
|
Magnesium | 1 | 2000 | 163 | 0.010 |
Why?
|
Swine | 2 | 1995 | 1610 | 0.010 |
Why?
|
Sympatholytics | 1 | 1998 | 5 | 0.010 |
Why?
|
Feedback | 1 | 2000 | 217 | 0.010 |
Why?
|
Receptor, Bradykinin B2 | 1 | 1998 | 1 | 0.010 |
Why?
|
Sympathomimetics | 1 | 1998 | 16 | 0.010 |
Why?
|
Nicotinic Agonists | 1 | 1999 | 120 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 14855 | 0.010 |
Why?
|
Chlorpheniramine | 1 | 1997 | 1 | 0.010 |
Why?
|
Dimaprit | 1 | 1997 | 1 | 0.010 |
Why?
|
Methylhistamines | 1 | 1997 | 2 | 0.010 |
Why?
|
Pyrilamine | 1 | 1997 | 2 | 0.010 |
Why?
|
Adrenergic Agents | 1 | 1997 | 19 | 0.010 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 1998 | 184 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2010 | 3955 | 0.010 |
Why?
|
Arterial Occlusive Diseases | 1 | 1998 | 168 | 0.010 |
Why?
|
Duodenum | 1 | 1997 | 154 | 0.010 |
Why?
|
Neurotransmitter Agents | 1 | 1997 | 166 | 0.010 |
Why?
|
Partial Pressure | 1 | 1996 | 39 | 0.010 |
Why?
|
Amino Acids | 1 | 2000 | 760 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 4895 | 0.010 |
Why?
|
Free Radical Scavengers | 1 | 1995 | 83 | 0.010 |
Why?
|
Cell Aggregation | 1 | 1995 | 59 | 0.010 |
Why?
|
Transfection | 1 | 2000 | 2989 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2001 | 3518 | 0.010 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 1994 | 11 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 1995 | 154 | 0.010 |
Why?
|
Diastole | 1 | 1995 | 188 | 0.010 |
Why?
|
Sex Factors | 1 | 1999 | 2217 | 0.010 |
Why?
|
Hydroxides | 1 | 1993 | 8 | 0.010 |
Why?
|
Reperfusion | 1 | 1993 | 25 | 0.010 |
Why?
|
Free Radicals | 1 | 1993 | 63 | 0.010 |
Why?
|
Iron | 1 | 1995 | 381 | 0.010 |
Why?
|
Oxygen | 1 | 1996 | 781 | 0.010 |
Why?
|
Ultrasonography | 1 | 1998 | 1926 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 1995 | 615 | 0.010 |
Why?
|
Algorithms | 1 | 1999 | 3988 | 0.000 |
Why?
|
Cell Movement | 1 | 1993 | 2499 | 0.000 |
Why?
|
Aged | 1 | 1989 | 72902 | 0.000 |
Why?
|
Middle Aged | 1 | 1989 | 89535 | 0.000 |
Why?
|